MACKENZIE WESTPHAL: Open Payments
NPI 1801548672 · MISSOULA, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$881 in 30 payments from 4 companies in 2025. Trend: 2023 $1,410 · 2024 $268 · 2025 $881
Food & beverage: $770Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $531 |
| Teva Pharmaceuticals USA, Inc. | 7 | $173 |
| E.R. Squibb & Sons, L.L.C. | 1 | $96 |
| TG Therapeutics, Inc. | 1 | $82 |
Products named: UBRELVY, QULIPTA, ZEPOSIA, BRIUMVI, AUSTEDO XR.
Industry payments across MT — which companies pay providers there.
